Betaine anhydrous in homocystinuria: results from the RoCH registry

Abstract Background The Registry of Adult and Paediatric Patients Treated with Cystadane® – Homocystinuria (RoCH) is a non-interventional, observational, multi-centre, post-authorization safety study that aimed to identify safety of betaine anhydrous (Cystadane®) in the treatment of patients with in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vassili Valayannopoulos, Manuel Schiff, Nathalie Guffon, Yann Nadjar, Angels García-Cazorla, Mercedes Martinez-Pardo Casanova, Aline Cano, Maria L. Couce, Jaime Dalmau, Luis Peña-Quintana, Vincent Rigalleau, Guy Touati, Luis Aldamiz-Echevarria, Pascal Cathebras, Didier Eyer, Dominique Brunet, Léna Damaj, Dries Dobbelaere, Claire Gay, Sylvie Hiéronimus, Virginie Levrat, François Maillot
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2019-03-01
Edice:Orphanet Journal of Rare Diseases
Témata:
Betaine anhydrous
Efficacy
Homocystinuria
RoCH registry
Safety
On-line přístup:http://link.springer.com/article/10.1186/s13023-019-1036-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky